Tagged Articles

Zecurity 2 articles

Migraine patch Zecurity discontinued due to burn risk

After numerous complaints of burns and scarring allegedly caused by the migraine patch Zecurity, Teva Pharmaceuticals Industries announced it has discontinued making the patch and it is no longer available. Zecurity is an iontophoretic transdermal system used to treat acute migraine for adults. It delivers a therapeutic dose of the active ingredient sumatriptan via a single-use, battery-powered patch wrapped around the upper arm or thigh. Since the patch hit the market in September 2015, the company has been rife with reports of skin reactions where the patch was applied. Reactions reported include severe redness, pain, skin discoloration, blistering and cracked ... Read More

FDA approves first-ever migraine medicine skin patch

NuPathe is launching the first-ever patch to treat migraine headache, a product the device’s maker says is “game changing” to migraine sufferers. The Food and Drug Administration (FDA) gave NuPathe’s Zecuity the nod last week, and the company says it is currently focusing on securing commercial partners for the patch and hopes to have the patch on the market by the end of the year. Zecuity is a single-use, battery-powered patch that actively delivers the migraine medication sumatriptan through the skin. Sumatriptan has been on the market since 1991. It is administered in several forms including tablets, subcutaneous injection, and ... Read More